BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9554149)

  • 1. [Establishing the types of Dienes compatibility in clinical Proteus mirabilis strains].
    Józefowicz-Piatkowska H
    Med Dosw Mikrobiol; 1997; 49(3-4):169-76. PubMed ID: 9554149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of bacteriocinogenic types of strains of Proteus mirabilis].
    Józefowicz-Piatkowska H; Piatkowski K
    Med Dosw Mikrobiol; 1994; 46(3):151-60. PubMed ID: 7996932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the usefulness of standard strains sets from the senior collection for typing Proteus mirabilis strains].
    Aleksandrowicz I; Samet A
    Med Dosw Mikrobiol; 1994; 46(4):285-91. PubMed ID: 7603129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug resistance and proticinogenic types of Proteus mirabilis isolated from urinary tract infections].
    Szymaniak L; Aleksandrowicz I; Giedrys-Kalemba S
    Med Dosw Mikrobiol; 1999; 51(3-4):323-30. PubMed ID: 10803261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of Proteus mirabilis and Proteus vulgaris strains by means of proticine typing: a longitudinal epidemiological study.
    Sekaninová G; Kolárová M
    Cent Eur J Public Health; 1996 May; 4(2):98-101. PubMed ID: 8996720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigations made to test the demarcation line method (DLM) after Dienes for its suitability in the epidemiology of Proteus mirabilis (author's transl)].
    Sohnius I; Lenk V
    Zentralbl Bakteriol Orig B; 1977; 164(4):384-9. PubMed ID: 329623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and serological properties of the O-antigen of two clinical Proteus mirabilis strains classified into a new Proteus O77 serogroup.
    Drzewiecka D; Arbatsky NP; Shashkov AS; Staczek P; Knirel YA; Sidorczyk Z
    FEMS Immunol Med Microbiol; 2008 Nov; 54(2):185-94. PubMed ID: 18665848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A highly discriminatory multi-typing scheme for Proteus mirabilis and Proteus vulgaris.
    Senior BW; Larsson P
    J Med Microbiol; 1983 May; 16(2):193-202. PubMed ID: 6188832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proticine typing of serologically defined Proteus strains.
    Csiszár K; Lányi B
    Acta Microbiol Acad Sci Hung; 1981; 28(1):111-8. PubMed ID: 7020353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Typing of proteus from patients with bacteriuria.
    Clarke SC; McIntyre M
    J R Soc Health; 1996 Feb; 116(1):27-9. PubMed ID: 8683538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the discriminatory powers of the Dienes test and ribotyping as typing methods for Proteus mirabilis.
    Pfaller MA; Mujeeb I; Hollis RJ; Jones RN; Doern GV
    J Clin Microbiol; 2000 Mar; 38(3):1077-80. PubMed ID: 10699000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serologic studies of cross reactions between strains of Proteus mirabilis OXK (prO 10/52) and Proteus mirabilis S1959].
    Swierzko AS; Cedzyński M; Ziółkowski A; Kaca W
    Postepy Hig Med Dosw; 1996; 50(5):507-9. PubMed ID: 9072766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotyping of clinical isolates belonging to Proteus mirabilis serogroup O36 and structural elucidation of the O36-antigen polysaccharide.
    Arabski M; Grabowski S; Konieczna I; Kaca W; Kondakova AN; Perepelov AV; Senchenkova SN; Shashkov AS; Knirel YA
    FEMS Immunol Med Microbiol; 2008 Aug; 53(3):395-403. PubMed ID: 18625011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmid-mediated multiple antibiotic resistance in Proteus mirabilis isolated from patients with urinary tract infection.
    Khan AU; Musharraf A
    Med Sci Monit; 2004 Nov; 10(11):CR598-602. PubMed ID: 15507850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of Proteus mirabilis by bacteriophage typing and the Dienes reaction.
    Hickman FW; Farmer JJ
    J Clin Microbiol; 1976 Mar; 3(3):350-8. PubMed ID: 773962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Further types of core lipopolysaccharides in Proteus].
    Radziejewska-Lebrecht J; Zych K; Lipińska M; Sidorczyk Z
    Med Dosw Mikrobiol; 1993; 45(1):65-8. PubMed ID: 8231446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structures and serology of the O-antigens of Proteus strains classified into serogroup O17 and former serogroup O35.
    Torzewska A; Grabowski S; Kondakova AN; Toukach FV; Senchenkova SN; Shashkov AS; Arbatsky NP; Knirel YA; Rózalski A; Kaca W
    Arch Immunol Ther Exp (Warsz); 2006; 54(4):277-82. PubMed ID: 16868723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tandem tetramer-based microsatellite fingerprinting for typing of Proteus mirabilis strains.
    Cieślikowski T; Gradecka D; Mielczarek M; Kaca W
    J Clin Microbiol; 2003 Apr; 41(4):1673-80. PubMed ID: 12682159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical differentiation of proteus strains from various clinical materials].
    Józefowicz-Piatkowska H; Woch G
    Med Dosw Mikrobiol; 1993; 45(2):237-40. PubMed ID: 8309305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification of Proteus mirabilis chromosomal DNA using the polymerase chain reaction.
    Mansy MS; Fadl AA; Ashour MS; Khan MI
    Mol Cell Probes; 1999 Apr; 13(2):133-40. PubMed ID: 10208804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.